Ozempic Emotional Eating: Why GLP-1 Drugs Work for Some Personalities and Fail for Others

# Ozempic Emotional Eating: Why GLP-1 Drugs Work for Some Personalities and Fail for Others

> **Quick answer:** New research shows that Ozempic and other GLP-1 drugs produce dramatically different outcomes depending on why you overeat. External eaters — triggered by the sight or smell of food — see sustained weight loss over 12 months. Emotional eaters see early improvements that reverse to baseline by month 12. A separate Penn Medicine study found GLP-1 drugs quiet food-noise brain signals only temporarily. Your eating personality type is now a clinically relevant predictor of GLP-1 success.

*This article is for informational purposes only and does not constitute medical or psychiatric advice. Consult a qualified healthcare provider before starting, stopping, or changing any weight loss medication.*

Ozempic and its GLP-1 cousins — Wegovy, Mounjaro, and the newer oral Rybelsus — have reshaped the weight loss conversation. But buried beneath the headlines is a question that tens of millions of patients haven't been asked: does your eating psychology determine whether these drugs actually work? In 2026, the research answer is increasingly clear, and for emotional eaters, it is not what the marketing implied.

## The Kyoto Study: Your Eating Type Determines Your 12-Month Outcome

Researchers at Kyoto University and Gifu University conducted a 12-month prospective study tracking 92 adults with type 2 diabetes on GLP-1 therapy in Gifu Prefecture, Japan. The study, published in *Frontiers in Clinical Diabetes and Healthcare* in May 2026, used the Dutch Eating Behavior Questionnaire (DEBQ) — a validated clinical instrument — to classify participants into three eating personality profiles at baseline, at three months, and at twelve months.